WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000057866) USE OF AZALIDE ANTIBIOTICS FOR THE TOPICAL TREATMENT OR PREVENTION OF OCULAR INFECTIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/057866    International Application No.:    PCT/US2000/007924
Publication Date: 05.10.2000 International Filing Date: 27.03.2000
Chapter 2 Demand Filed:    04.10.2000    
IPC:
A61K 31/7048 (2006.01)
Applicants: INSITE VISION INCORPORATED [US/US]; 965 Atlantic Avenue, Alameda, CA 94501 (US) (For All Designated States Except US).
DAWSON, Chandler, R. [US/US]; (US) (For US Only).
BOWMAN, Lyle, M. [US/US]; (US) (For US Only)
Inventors: DAWSON, Chandler, R.; (US).
BOWMAN, Lyle, M.; (US)
Agent: FREED, Joel, M.; Howrey Simon Arnold & White, LLP, 1299 Pennsylvania Avenue, N.W., Box 34, Washington, DC 20004-2402 (US)
Priority Data:
09/282,165 31.03.1999 US
09/346,923 02.07.1999 US
Title (EN) USE OF AZALIDE ANTIBIOTICS FOR THE TOPICAL TREATMENT OR PREVENTION OF OCULAR INFECTIONS
(FR) TRAITEMENT OU PREVENTION TOPIQUE D'INFECTIONS OCULAIRES
Abstract: front page image
(EN)The topical application of an azalide antibiotic such as azithromycin to the eye is useful in treating or preventing ocular infections. In one embodiment, the azalide antibiotic is supplied to the eye in a depot for sustained release. A more convenient dosing regimen can also be provided by the use of an appropriate depot. Furthermore, a composition containing a combination of medicaments is also provided.
(FR)L'invention concerne l'application topique sur l'oeil d'un antibiotique de la classe des azalides, tel que l'azithromycine, utile pour le traitement ou la prévention des infections oculaires. Selon un mode de réalisation, on administre l'azalide dans l'oeil sous forme de dépôt en vue de sa libération prolongée. On peut obtenir un schéma posologique plus adapté par l'utilisation d'un dépôt approprié. En outre, l'invention concerne une composition contenant une combinaison de médicaments.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)